Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The characterization of the electronic structure and chemical states at heterogeneous interfaces (e.g., gas-solid or liquid-solid) can be effectively achieved using ambient pressure x-ray photoelectron spectroscopy (AP-XPS). However, acquiring these properties under plasma conditions remains a significant challenge. In this study, we introduce an AP-XPS system equipped with a custom-built spatially confined plasma source. This configuration confines the plasma to a controlled region, with the plasma intensity precisely regulated by adjusting either the working distance or the applied voltage. This system enables the direct detection of plasma electrons and the real-time characterization of surface states during plasma-surface interactions. To validate its efficacy and versatility, we conducted two proof-of-concept experiments: argon (Ar) plasma etching of graphene and oxygen (O2) plasma oxidation of platinum (Pt). The results demonstrate that the Ar plasma effectively etches graphene, as evidenced by distinct changes in the XPS spectra. Similarly, the exposure of a Pt surface to the oxygen plasma induces pronounced surface oxidation. This system significantly extends the operando capabilities of AP-XPS for in situ studies of plasma-enhanced reactions. Its application holds considerable promise for advancing fundamental and applied research in materials science and chemical engineering, particularly in the areas of surface modification and catalytic processes.

Download full-text PDF

Source
http://dx.doi.org/10.1063/5.0249456DOI Listing

Publication Analysis

Top Keywords

plasma
11
ambient pressure
8
pressure x-ray
8
x-ray photoelectron
8
photoelectron spectroscopy
8
plasma source
8
oxygen plasma
8
extending ambient
4
spectroscopy plasma
4
plasma studies
4

Similar Publications

Background: Following SARS-CoV-2 infection, ~10-35% of COVID-19 patients experience long COVID (LC), in which debilitating symptoms persist for at least three months. Elucidating biologic underpinnings of LC could identify therapeutic opportunities.

Methods: We utilized machine learning methods on biologic analytes provided over 12-months after hospital discharge from >500 COVID-19 patients in the IMPACC cohort to identify a multi-omics "recovery factor", trained on patient-reported physical function survey scores.

View Article and Find Full Text PDF

3-O-sulfation of heparan sulfate (HS) is the key determinant for binding and activation of Antithrombin III (AT). This interaction is the basis of heparin treatment to prevent thrombotic events and excess coagulation. Antithrombin-binding HS (HSAT) is expressed in human tissues, but is thought to be expressed in the subendothelial space, mast cells, and follicular fluid.

View Article and Find Full Text PDF

Agonist-induced interaction of G protein-coupled receptors (GPCRs) with β-arrestins (βarrs) is a critical mechanism that regulates the spatiotemporal pattern of receptor localization and signaling. While the underlying mechanism governing GPCR-βarr interaction is primarily conserved and involves receptor activation and phosphorylation, there are several examples of receptor-specific fine-tuning of βarr-mediated functional outcomes. Considering the key contribution of conformational plasticity of βarrs in driving receptor-specific functional responses, it is important to develop novel sensors capable of reporting distinct βarr conformations in cellular context.

View Article and Find Full Text PDF

Lymphotoxin β receptor (LTβR/TNFRSF3) signaling plays a crucial role in immune defense. Notably, LTβR-deficient (LTβR) mice exhibit severe defects in innate and adaptive immunity against various pathogens and succumb to infection. Here, we investigated the bone marrow (BM) and peritoneal cavity (PerC) compartments of LTβR mice during infection, demonstrating perturbed B-cell and T-cell subpopulations in the absence of LTβR signaling.

View Article and Find Full Text PDF

The purpose of this study was to evaluate the pharmacokinetics of oral (PO) ondansetron compared to intravenous (IV) ondansetron in eight healthy client-owned dogs. Dogs were randomized to one of two protocols in a crossover design, receiving PO or IV ondansetron at a dose of 1 mg/kg on Day 0 and the opposite formulation at an equal dose on Day 7. Plasma was collected at baseline and 1, 2, 4, and 8 h post administration.

View Article and Find Full Text PDF